Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy
Authors:
- Leonie M. KurzlechnerLKLeonie M. Kurzlechner
- Edward G. JonesEJEdward G. Jones
- Amy M. BerkmanABAmy M. Berkman
- Hanna J. TadrosHTHanna J. Tadros
- Jill A. RosenfeldJRJill A. Rosenfeld
- Yaping YangYYYaping Yang
- Hari TunuguntlaHTHari Tunuguntla
- Hugh D. AllenHAHugh D. Allen
- Jeffrey J. KimJKJeffrey J. Kim
- Andrew P. LandstromALAndrew P. Landstrom
Open Access
- 30 April 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (5) , 733
Abstract
Background: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and can predispose individuals to sudden death. Most pediatric HCM patients host a known pathogenic variant in a sarcomeric gene. With the increase in exome sequencing (ES) in clinical settings, incidental variants in HCM-associated genes are being identified more frequently. Diagnostic interpretation of incidental variants is crucial to enhance clinical patient management. We sought to use amino acid-level signal-to-noise (S:N) analysis to establish pathogenic hotspots in sarcomeric HCM-associated genes as well as to refine the 2015 American College of Medical Genetics (ACMG) criteria to predict incidental variant pathogenicity. Methods and Results: Incidental variants in HCM genes (MYBPC3, MYH7, MYL2, MYL3, ACTC1, TPM1, TNNT2, TNNI3, and TNNC1) were obtained from a clinical ES referral database (Baylor Genetics) and compared to rare population variants (gnomAD) and variants from HCM literature cohort studies. A subset of the ES cohort was clinically evaluated at Texas Children’s Hospital. We compared the frequency of ES and HCM variants at specific amino acid locations in coding regions to rare variants (MAF < 0.0001) in gnomAD. S:N ratios were calculated at the gene- and amino acid-level to identify pathogenic hotspots. ES cohort variants were re-classified using ACMG criteria with S:N analysis as a correlate for PM1 criteria, which reduced the burden of variants of uncertain significance. In the clinical validation cohort, the majority of probands with cardiomyopathy or family history hosted likely pathogenic or pathogenic variants. Conclusions: Incidental variants in HCM-associated genes were common among clinical ES referrals, although the majority were not disease-associated. Leveraging amino acid-level S:N as a clinical tool may improve the diagnostic discriminatory ability of ACMG criteria by identifying pathogenic hotspots.Keywords
Funding Information
- National Institutes of Health (K08-HL136839, R38-HL143612)
- American Academy of Pediatrics (K08-HL136839, R38-HL143612)
- Children’s Cardiomyopathy Foundation (K08-HL136839, R38-HL143612)
- Derfner Foundation (K08-HL136839, R38-HL143612)
This publication has 32 references indexed in Scilit:
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Sarcomeric hypertrophic cardiomyopathy: Genetic profile in a Portuguese populationRevista Portuguesa de Cardiologia, 2012
- Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study CohortsThe American Journal of Human Genetics, 2012
- Genetics of Hypertrophic Cardiomyopathy After 20 YearsJACC, 2012
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathyThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Exome sequencing as a tool for Mendelian disease gene discoveryNature Reviews Genetics, 2011
- Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathyEuropean Journal of Medical Genetics, 2010
- Genetics of hypertrophic cardiomyopathyCurrent Opinion in Cardiology, 2010
- Hypertrophic CardiomyopathyJAMA, 2002
- Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.Proceedings of the National Academy of Sciences, 1995